ALOIN (b)

CAS No. 8015-61-0

ALOIN (b)( —— )

Catalog No. M20358 CAS No. 8015-61-0

ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 84 In Stock
10MG 116 In Stock
25MG 187 In Stock
50MG 259 In Stock
100MG 361 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ALOIN (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
  • Description
    ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP|IL Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    8015-61-0
  • Formula Weight
    418.39
  • Molecular Formula
    C21H22O9?
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (239.01 mM)
  • SMILES
    [H][C@@]1([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cccc(O)c2C(=O)c2c(O)cc(CO)cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Barrantes E Guinea M . Inhibition of collagenase and metalloproteinases by aloins and aloe gel[J]. Life Sciences 2003 72(7):0-850.
molnova catalog
related products
  • Colistimethate Sodiu...

    Colistimethate Sodium is used for the treatment of serious infections due to selected aerobic Gram-negative pathogens in patients with limited treatment options.

  • DB04760

    DB04760 is a highly selective, non-zinc-chelating inhibitor of MMP-13 (IC50: 8 nM). DB04760 obviously decreases paclitaxel neurotoxicity and has anticancer activity.

  • Lucidenic acid C

    Lucidenic acid C is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells.